the sun malaysia ipaper logo 150x150
Friday, July 3, 2026
27.5 C
Kuala Lumpur
the sun malaysia ipaper logo 150x150

King presents instrument of appointment to new Malaysian Ambassador to the US

KUALA LUMPUR: His Majesty Sultan Ibrahim, King of Malaysia, presented the instrument of appointment to the new Malaysian Ambassador to the United States, Tan Sri Muhammad Shahrul Ikram Yaakob, in a ceremony at Istana Negara today.

Muhammad Shahrul Ikram is the former Foreign Ministry’s secretary-general.

According to a post on Sultan Ibrahim’s Facebook page, the ceremony was also attended by the Deputy Foreign Minister Datuk Mohamad Alamin and the ministry’s secretary-general Datuk Sri Amran Mohamed Zin.

Muhammad Shahrul Ikram replaces Datuk Seri Nazri Aziz, whose term concluded on Feb 8.

The Pahang-born Muhammad Shahrul Ikram holds a Bachelor of Science (Hons) in Ecology from Universiti Malaya and has attended the Advanced Management Program at Harvard Business School in the US.

He started his career as an Administrative and Diplomatic Officer in the Foreign Ministry in 1988 and served as the ministry’s secretary-general from Jan 6, 2019, to May 31, 2022.

Throughout his 35 years in public service, Muhammad Shahrul Ikram has been posted as Malaysian Ambassador to Qatar, Malaysian Ambassador to Austria and Permanent Representative of Malaysia to the United Nations in New York.

While at the Foreign Ministry, he had served as deputy secretary-general (Bilateral Relations), director-general of the ASEAN-Malaysia National Secretariat (during Malaysia’s 2015 ASEAN Chairmanship) and Secretary of the Multilateral Political Division.

His other previous diplomatic assignments include the Malaysian missions in Vienna, Washington, and Beijing.

STAY AHEAD OF THE CURVE

Join our community for instant updates and exclusive content.

Join Telegram Channel

Related


spot_img

Latest News

Bora Pharmaceuticals Completes Acquisition of MacroGenics’ Rockville Manufacturing Operations

TAIPEI, TAIWAN - Media OutReach Newswire - 2 July 2026 - Bora Pharmaceuticals Co., Ltd. ("Bora" or "Bora Group"; TWSE: 6472; OTCQX: BORAY) today announced the completion of its acquisition of the GMP manufacturing operations of MacroGenics, Inc. (NASDAQ: MGNX) including its biologics drug substance facility in Rockville, Maryland and an associated warehousing center in Frederick, Maryland, for total consideration of US $122.5 million through its wholly owned subsidiary Bora Biologics USA, LLC.. Upon closing, Bora signed a long-term CDMO Service Agreement with MacroGenics.

Most Viewed

spot_img
WC26

World Cup 2026

Updates, Fixtures, Results & Standings